Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Indian Journal of Pharmaceutical Sciences|May 12, 2016
Combating Tuberculosis Infection: A Forbidding ChallengeTejal Rawal, Shital ButaniAAPS Pharmscitech|February 12, 2022
Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic StudyAmarjitsing Rajput, Shital ButaniNaunyn-Schmiedeberg'S Archives of Pharmacology|November 11, 2024
Next-generation cancer nanotherapeutics: Pluronic® F127 based mixed micelles for enhanced drug deliveryKrishna Bhalodi, Charmy Kothari, Shital ButaniEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2018
Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquilineTejal Rawal, Snehal Patel, Shital ButaniJournal of Aerosol Medicine and Pulmonary Drug Delivery|May 17, 2017
Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar TuberculosisTejal Rawal, Laurent Kremer, Iman Halloum, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|January 30, 2025
Lowering LDL cholesterol by PCSK9 inhibition: a new era of gene silencing, RNA, and alternative therapiesMitali Paryani, Nikita Gupta, Sanjay Kumar Jain, et al.Colloids and Surfaces. B, Biointerfaces|April 1, 2017
Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosisTejal Rawal, Rajesh Parmar, Rajeev K Tyagi, et al.Pharmaceutical Research|August 5, 2022
Process Modelling, Scale-Up and Characterization of Acetaminophen Spray Dried Milk Powder as Novel Pediatric Dosage FormHarsh S Shah, Urmilasri Syamala, Khushbu Chaudhari, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 19, 2026
Inhalable quercetin dihydrate nanosuspension mitigates silica-induced pulmonary fibrosis in ratsNikita Gupta, Mitali Paryani, Jahanvee Kumar, et al.Reproductive Sciences (Thousand Oaks, Calif.)|October 13, 2021
PCOS and Depression: Common Links and Potential TargetsJagruti V Kolhe, Abu Sufiyan Chhipa, Shital Butani, et al.Pageof 2